BLRX

BioLineRX

19 hedge funds and large institutions have $17.9M invested in BioLineRX in 2014 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 5 closing their positions.

Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
6
Reduced
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$4.24M 1,902,800 +1,902,800 New
SM
2
Senvest Management
New York
$3.46M 1,549,805 +819,495 +112%
OM
3
Opaleye Management
Massachusetts
$3.24M 1,451,000 +738,000 +104%
O
4
OrbiMed
New York
$2.53M 1,135,000
BI
5
BVF Inc
California
$1.78M 800,000 +800,000 New
SFM
6
Sphera Funds Management
Israel
$1.34M 600,000 +600,000 New
Deutsche Bank
7
Deutsche Bank
Germany
$497K 223,050 +78,800 +55%
PA
8
Perceptive Advisors
New York
$399K 179,041 +179,041 New
Jane Street
9
Jane Street
New York
$130K 59,063 +59,063 New
Citadel Advisors
10
Citadel Advisors
Florida
$72K 32,373 +32,373 New
Renaissance Technologies
11
Renaissance Technologies
New York
$60K 26,800 +16,600 +163%
BCA
12
Benchmark Capital Advisors
New York
$45K 20,000 +20,000 New
VKH
13
Virtu KCG Holdings
New York
$41K 18,640 +5,511 +42%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$40K 17,800
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$27K 12,000
Morgan Stanley
16
Morgan Stanley
New York
$21K 9,391 +9,391 New
U
17
UBS
Switzerland
$7K 2,967 +2,967 New
Wells Fargo
18
Wells Fargo
California
$2K 1,000
Citigroup
19
Citigroup
New York
$2K 826 +779 +1,657%
UBS AM
20
UBS AM
Illinois
-30,000 Closed
ARTA
21
A.R.T. Advisors
New York
-10,042 Closed
TRCT
22
Tower Research Capital (TRC)
New York
-10,008 Closed
Creative Planning
23
Creative Planning
Kansas
-140 Closed
Ameriprise
24
Ameriprise
Minnesota
-10 Closed